Suchbegriffe: RECEPTORS, CYTOPLASMIC AND NUCLEAR - BLOOD , . Treffer: 4
Herrmann, M; Herrmann, W
The assessment of bone metabolism in female elite endurance athletes by biochemical bone markers.
Clin Chem Lab Med. 2004; 42(12):1384-1389
Doi: 10.1515/CCLM.2004.258
Web of Science
PubMed
FullText
FullText_MUG
Fahrleitner, A; Prenner, G; Leb, G; Tscheliessnigg, KH; Piswanger-Sölkner, C; Obermayer-Pietsch, B; Portugaller, HR; Berghold, A; Dobnig, H
Serum osteoprotegerin is a major determinant of bone density development and prevalent vertebral fracture status following cardiac transplantation.
Bone. 2003; 32(1):96-106
Doi: 10.1016%2FS8756-3282%2802%2900926-2
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Fahrleitner-Pammer, A; Dobnig, H; Piswanger-Soelkner, C; Bonelli, C; Dimai, HP; Leb, G; Obermayer-Pietsch, B
Osteoprotegerin serum levels in women: correlation with age, bone mass, bone turnover and fracture status.
Wien Klin Wochenschr. 2003; 115(9):291-297
Doi: 10.1007/BF03040334
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Fahrleitner, A; Prenner, G; Kniepeiss, D; Iberer, F; Tscheliessnigg, KH; Piswanger-Sölkner, C; Obermayer-Pietsch, B; Leb, G; Dobnig, H
Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status.
Wien Klin Wochenschr. 2002; 114(15-16):717-724
Web of Science
PubMed
Google Scholar